Assessment of Anti-Factor Xa Levels in Children Receiving Low-Molecular-Weight Heparin for Treatment and Prophylaxis

Background: The use of low-molecular-weight heparins (LMWH) for the treatment and prevention of thromboembolic diseases in pediatric patients is increasing, although optimal dosing and monitoring strategies remain insufficiently defined. Methods: This study was conducted at the Clinic of Pediatrics,...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Margarita Panova, Maria Spasova, Snezhana Stoencheva, Teodora Dimcheva, Iglika Sotkova-Ivanova, Pamela Boykova
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2026-06-01
סדרה:	Children
נושאים:	low-molecular-weight heparin enoxaparin anti-factor Xa monitoring pediatric thrombosis anticoagulation
גישה מקוונת:	https://www.mdpi.com/2227-9067/13/6/792
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!